Tapewire

Nasdaq · USD

TNDM

TANDEM DIABETES CARE INC

Export transactions ↓
Tapewire entity
4682
SEC CIK
0001438133
Parsed reports
672

Last 12 months

Inside the activity.

0 purchase rows · 2 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202602
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
May 22, 2023 Filed May 23, 2023 00:10 UTC
Allen DickDirector
GiftCommon Stock 1,000 $29.17 $29,165.00
Disclosure

SEC source: 0001438133-23-000092 · wf-form4_168480062273571.xml · nonDerivative · entry 4

Allen Dick · CIK 0001582779 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnotes

Disclosed balance after: 0

F3 · kind: The shares were given as a bona fide gift to Hannah Lee Gammon.

F4 · price: The price per share reflects the average of the high and low trading prices of the Company's stock on the transaction date.

F5 · ownership.nature: The securities are held by the Gammon Children's 2000 Trust FBO Hannah Lee Gammon. The Reporting Person is co-trustee of the Gammon Children's 2000 Trust FBO Hannah Lee Gammon and has shared voting and investment power over the securities held by the Gammon Children's 2000 Trust FBO Hannah Lee Gammon and may be deemed to have indirect beneficial ownership of such securities. The Reporting Person disclaims beneficial ownership of such securities held by the Gammon Children's 2000 Trust FBO Hannah Lee Gammon.

Read SEC document
May 18, 2023 Filed May 23, 2023 00:10 UTC
Allen DickDirector
PurchaseCommon Stock 10,000 $29.47 $294,687.00
Disclosure

SEC source: 0001438133-23-000092 · wf-form4_168480062273571.xml · nonDerivative · entry 1

Allen Dick · CIK 0001582779 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,205

Read SEC document
May 17, 2023 Filed May 19, 2023 20:18 UTC PurchaseCommon Stock 3,000 $30.16 $90,492.00
Disclosure

SEC source: 0001438133-23-000090 · wf-form4_168452751088445.xml · nonDerivative · entry 1

Howell Peyton R · CIK 0001528056 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,550

Read SEC document
May 15, 2023 Filed May 17, 2023 18:08 UTC
Leal JamesChief Manufacturing Officer
GrantRestricted Stock Unit · Derivative 6,898 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000080 · wf-form4_168436130062849.xml · derivative · entry 8

Leal James · CIK 0001866570 · Chief Manufacturing Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,796

Underlying: Common Stock · 6,898 shares

Expires not disclosed

F3 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan).

F6 · derivative.exercise_date: RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

F6 · derivative.expiration_date: RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

Read SEC document
May 15, 2023 Filed May 17, 2023 18:08 UTC
Leal JamesChief Manufacturing Officer
Exercise / conversionRestricted Stock Unit · Derivative 3,223 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000080 · wf-form4_168436130062849.xml · derivative · entry 7

Leal James · CIK 0001866570 · Chief Manufacturing Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,446

Underlying: Common Stock · 3,223 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan).

F5 · derivative.exercise_date: RSU granted on 5/25/2022 vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

F5 · derivative.expiration_date: RSU granted on 5/25/2022 vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

Read SEC document
May 15, 2023 Filed May 17, 2023 18:08 UTC
Leal JamesChief Manufacturing Officer
Exercise / conversionRestricted Stock Unit · Derivative 168 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000080 · wf-form4_168436130062849.xml · derivative · entry 6

Leal James · CIK 0001866570 · Chief Manufacturing Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,340

Underlying: Common Stock · 168 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan).

F4 · derivative.exercise_date: RSU granted on 5/18/2021 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

F4 · derivative.expiration_date: RSU granted on 5/18/2021 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

Read SEC document
May 15, 2023 Filed May 17, 2023 18:08 UTC
Leal JamesChief Manufacturing Officer
Tax withholdingCommon Stock 1,333 $32.13 $42,829.29
Disclosure

SEC source: 0001438133-23-000080 · wf-form4_168436130062849.xml · nonDerivative · entry 5

Leal James · CIK 0001866570 · Chief Manufacturing Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,415

F2 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
May 15, 2023 Filed May 17, 2023 18:08 UTC
Leal JamesChief Manufacturing Officer
Exercise / conversionCommon Stock 3,223 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000080 · wf-form4_168436130062849.xml · nonDerivative · entry 4

Leal James · CIK 0001866570 · Chief Manufacturing Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,748

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 15, 2023 Filed May 17, 2023 18:08 UTC
Leal JamesChief Manufacturing Officer
Tax withholdingCommon Stock 70 $32.13 $2,249.10
Disclosure

SEC source: 0001438133-23-000080 · wf-form4_168436130062849.xml · nonDerivative · entry 3

Leal James · CIK 0001866570 · Chief Manufacturing Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,525

F2 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
May 15, 2023 Filed May 17, 2023 18:08 UTC
Leal JamesChief Manufacturing Officer
Exercise / conversionCommon Stock 168 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000080 · wf-form4_168436130062849.xml · nonDerivative · entry 2

Leal James · CIK 0001866570 · Chief Manufacturing Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,595

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 15, 2023 Filed May 17, 2023 18:08 UTC
Leal JamesChief Manufacturing Officer
GrantCommon Stock 621 $27.32 $16,965.72
Disclosure

SEC source: 0001438133-23-000080 · wf-form4_168436130062849.xml · nonDerivative · entry 1

Leal James · CIK 0001866570 · Chief Manufacturing Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,427

F1 · shares: The reporting person is voluntarily reporting the acquisition of shares of common stock pursuant to the Tandem Diabetes Care, Inc. Amended and Restated 2013 Employee Stock Purchase Plan (ESPP), for the ESPP purchase period of November 16, 2022 through May 15, 2023. This transaction is also exempt under Rule 16b-3(c).

Read SEC document
May 15, 2023 Filed May 17, 2023 22:11 UTC
Gasser Elizabeth AnneEVP, Chief Strategy Officer
Exercise / conversionRestricted Stock Unit · Derivative 1,897 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000082 · wf-form4_168436148344720.xml · derivative · entry 6

Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,794

Underlying: Common Stock · 1,897 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan).

F4 · derivative.exercise_date: RSU granted on 5/25/2022 vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

F4 · derivative.expiration_date: RSU granted on 5/25/2022 vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

Read SEC document
May 15, 2023 Filed May 17, 2023 22:11 UTC
Gasser Elizabeth AnneEVP, Chief Strategy Officer
Exercise / conversionRestricted Stock Unit · Derivative 163 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000082 · wf-form4_168436148344720.xml · derivative · entry 5

Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,299

Underlying: Common Stock · 163 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan).

F3 · derivative.exercise_date: RSU granted on 5/18/2021 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

F3 · derivative.expiration_date: RSU granted on 5/18/2021 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

Read SEC document
May 15, 2023 Filed May 17, 2023 22:11 UTC
Gasser Elizabeth AnneEVP, Chief Strategy Officer
Tax withholdingCommon Stock 656 $32.13 $21,077.28
Disclosure

SEC source: 0001438133-23-000082 · wf-form4_168436148344720.xml · nonDerivative · entry 4

Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,679

F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
May 15, 2023 Filed May 17, 2023 22:11 UTC
Gasser Elizabeth AnneEVP, Chief Strategy Officer
Exercise / conversionCommon Stock 1,897 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000082 · wf-form4_168436148344720.xml · nonDerivative · entry 3

Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,335

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 15, 2023 Filed May 17, 2023 22:11 UTC
Gasser Elizabeth AnneEVP, Chief Strategy Officer
Tax withholdingCommon Stock 57 $32.13 $1,831.41
Disclosure

SEC source: 0001438133-23-000082 · wf-form4_168436148344720.xml · nonDerivative · entry 2

Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,438

F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
May 15, 2023 Filed May 17, 2023 22:11 UTC
Gasser Elizabeth AnneEVP, Chief Strategy Officer
Exercise / conversionCommon Stock 163 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000082 · wf-form4_168436148344720.xml · nonDerivative · entry 1

Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,495

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 15, 2023 Filed May 17, 2023 22:10 UTC
Vosseller LeighEVP & CHIEF FINANCIAL OFFICER
Exercise / conversionRestricted Stock Unit · Derivative 1,897 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000081 · wf-form4_168436140977215.xml · derivative · entry 8

Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,794

Underlying: Common Stock · 1,897 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan).

F6 · derivative.exercise_date: RSU granted on 5/25/2022 vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

F6 · derivative.expiration_date: RSU granted on 5/25/2022 vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

Read SEC document
May 15, 2023 Filed May 17, 2023 22:10 UTC
Vosseller LeighEVP & CHIEF FINANCIAL OFFICER
Exercise / conversionRestricted Stock Unit · Derivative 163 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000081 · wf-form4_168436140977215.xml · derivative · entry 7

Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,299

Underlying: Common Stock · 163 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan).

F5 · derivative.exercise_date: RSU granted on 5/18/2021 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

F5 · derivative.expiration_date: RSU granted on 5/18/2021 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

Read SEC document
May 15, 2023 Filed May 17, 2023 22:10 UTC
Vosseller LeighEVP & CHIEF FINANCIAL OFFICER
Tax withholdingCommon Stock 656 $32.13 $21,077.28
Disclosure

SEC source: 0001438133-23-000081 · wf-form4_168436140977215.xml · nonDerivative · entry 5

Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,672

F2 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
May 15, 2023 Filed May 17, 2023 22:10 UTC
Vosseller LeighEVP & CHIEF FINANCIAL OFFICER
Exercise / conversionCommon Stock 1,897 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000081 · wf-form4_168436140977215.xml · nonDerivative · entry 4

Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,328

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 15, 2023 Filed May 17, 2023 22:10 UTC
Vosseller LeighEVP & CHIEF FINANCIAL OFFICER
Tax withholdingCommon Stock 57 $32.13 $1,831.41
Disclosure

SEC source: 0001438133-23-000081 · wf-form4_168436140977215.xml · nonDerivative · entry 3

Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,431

F2 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
May 15, 2023 Filed May 17, 2023 22:10 UTC
Vosseller LeighEVP & CHIEF FINANCIAL OFFICER
Exercise / conversionCommon Stock 163 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000081 · wf-form4_168436140977215.xml · nonDerivative · entry 2

Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,488

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 15, 2023 Filed May 17, 2023 22:10 UTC
Vosseller LeighEVP & CHIEF FINANCIAL OFFICER
GrantCommon Stock 633 $27.32 $17,293.56
Disclosure

SEC source: 0001438133-23-000081 · wf-form4_168436140977215.xml · nonDerivative · entry 1

Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,325

F1 · shares: The reporting person is voluntarily reporting the acquisition of shares of common stock pursuant to the Tandem Diabetes Care, Inc. Amended and Restated 2013 Employee Stock Purchase Plan (ESPP), for the ESPP purchase period of November 16, 2022 through May 15, 2023. This transaction is also exempt under Rule 16b-3(c).

Read SEC document
May 15, 2023 Filed May 17, 2023 22:21 UTC
Sheridan John FDirector · PRESIDENT & CEO
Exercise / conversionRestricted Stock Unit · Derivative 8,945 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000088 · wf-form4_168436205507195.xml · derivative · entry 7

Sheridan John F · CIK 0001365369 · Director · PRESIDENT & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,891

Underlying: Common Stock · 8,945 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan).

F5 · derivative.exercise_date: RSU granted on 5/25/2022 vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

F5 · derivative.expiration_date: RSU granted on 5/25/2022 vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

Read SEC document
May 15, 2023 Filed May 17, 2023 22:21 UTC
Sheridan John FDirector · PRESIDENT & CEO
Exercise / conversionRestricted Stock Unit · Derivative 793 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000088 · wf-form4_168436205507195.xml · derivative · entry 6

Sheridan John F · CIK 0001365369 · Director · PRESIDENT & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,339

Underlying: Common Stock · 793 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan).

F4 · derivative.exercise_date: RSU granted on 5/18/2021 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

F4 · derivative.expiration_date: RSU granted on 5/18/2021 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

Read SEC document
May 15, 2023 Filed May 17, 2023 22:21 UTC
Sheridan John FDirector · PRESIDENT & CEO
Tax withholdingCommon Stock 3,094 $32.13 $99,410.22
Disclosure

SEC source: 0001438133-23-000088 · wf-form4_168436205507195.xml · nonDerivative · entry 5

Sheridan John F · CIK 0001365369 · Director · PRESIDENT & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,908

F2 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
May 15, 2023 Filed May 17, 2023 22:21 UTC
Sheridan John FDirector · PRESIDENT & CEO
Exercise / conversionCommon Stock 8,945 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000088 · wf-form4_168436205507195.xml · nonDerivative · entry 4

Sheridan John F · CIK 0001365369 · Director · PRESIDENT & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,002

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 15, 2023 Filed May 17, 2023 22:21 UTC
Sheridan John FDirector · PRESIDENT & CEO
Tax withholdingCommon Stock 275 $32.13 $8,835.75
Disclosure

SEC source: 0001438133-23-000088 · wf-form4_168436205507195.xml · nonDerivative · entry 3

Sheridan John F · CIK 0001365369 · Director · PRESIDENT & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,057

F2 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
May 15, 2023 Filed May 17, 2023 22:21 UTC
Sheridan John FDirector · PRESIDENT & CEO
Exercise / conversionCommon Stock 793 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000088 · wf-form4_168436205507195.xml · nonDerivative · entry 2

Sheridan John F · CIK 0001365369 · Director · PRESIDENT & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,332

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 15, 2023 Filed May 17, 2023 22:21 UTC
Sheridan John FDirector · PRESIDENT & CEO
GrantCommon Stock 560 $27.32 $15,299.20
Disclosure

SEC source: 0001438133-23-000088 · wf-form4_168436205507195.xml · nonDerivative · entry 1

Sheridan John F · CIK 0001365369 · Director · PRESIDENT & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,539

F1 · shares: The reporting person is voluntarily reporting the acquisition of shares of common stock pursuant to the Tandem Diabetes Care, Inc. Amended and Restated 2013 Employee Stock Purchase Plan (ESPP), for the ESPP purchase period of November 16, 2022 through May 15, 2023. This transaction is also exempt under Rule 16b-3(c).

Read SEC document
May 15, 2023 Filed May 17, 2023 22:19 UTC
Morrison SusanEVP & Chief Admin. Officer
Exercise / conversionRestricted Stock Unit · Derivative 1,897 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000087 · wf-form4_168436196003998.xml · derivative · entry 7

Morrison Susan · CIK 0001582970 · EVP & Chief Admin. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,794

Underlying: Common Stock · 1,897 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan).

F5 · derivative.exercise_date: RSU granted on 5/25/2022 vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

F5 · derivative.expiration_date: RSU granted on 5/25/2022 vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

Read SEC document
May 15, 2023 Filed May 17, 2023 22:19 UTC
Morrison SusanEVP & Chief Admin. Officer
Exercise / conversionRestricted Stock Unit · Derivative 163 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000087 · wf-form4_168436196003998.xml · derivative · entry 6

Morrison Susan · CIK 0001582970 · EVP & Chief Admin. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,299

Underlying: Common Stock · 163 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan).

F4 · derivative.exercise_date: RSU granted on 5/18/2021 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

F4 · derivative.expiration_date: RSU granted on 5/18/2021 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

Read SEC document
May 15, 2023 Filed May 17, 2023 22:19 UTC
Morrison SusanEVP & Chief Admin. Officer
Tax withholdingCommon Stock 539 $32.13 $17,318.07
Disclosure

SEC source: 0001438133-23-000087 · wf-form4_168436196003998.xml · nonDerivative · entry 5

Morrison Susan · CIK 0001582970 · EVP & Chief Admin. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,958

F2 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
May 15, 2023 Filed May 17, 2023 22:19 UTC
Morrison SusanEVP & Chief Admin. Officer
Exercise / conversionCommon Stock 1,897 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000087 · wf-form4_168436196003998.xml · nonDerivative · entry 4

Morrison Susan · CIK 0001582970 · EVP & Chief Admin. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,497

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 15, 2023 Filed May 17, 2023 22:19 UTC
Morrison SusanEVP & Chief Admin. Officer
Tax withholdingCommon Stock 47 $32.13 $1,510.11
Disclosure

SEC source: 0001438133-23-000087 · wf-form4_168436196003998.xml · nonDerivative · entry 3

Morrison Susan · CIK 0001582970 · EVP & Chief Admin. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,600

F2 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
May 15, 2023 Filed May 17, 2023 22:19 UTC
Morrison SusanEVP & Chief Admin. Officer
Exercise / conversionCommon Stock 163 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000087 · wf-form4_168436196003998.xml · nonDerivative · entry 2

Morrison Susan · CIK 0001582970 · EVP & Chief Admin. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,647

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 15, 2023 Filed May 17, 2023 22:19 UTC
Morrison SusanEVP & Chief Admin. Officer
GrantCommon Stock 633 $27.32 $17,293.56
Disclosure

SEC source: 0001438133-23-000087 · wf-form4_168436196003998.xml · nonDerivative · entry 1

Morrison Susan · CIK 0001582970 · EVP & Chief Admin. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,484

F1 · shares: The reporting person is voluntarily reporting the acquisition of shares of common stock pursuant to the Tandem Diabetes Care, Inc. Amended and Restated 2013 Employee Stock Purchase Plan (ESPP), for the ESPP purchase period of November 16, 2022 through May 15, 2023. This transaction is also exempt under Rule 16b-3(c).

Read SEC document
May 15, 2023 Filed May 17, 2023 22:18 UTC
BERGER DAVID BEVP & Chief Operating Officer
Exercise / conversionRestricted Stock Unit · Derivative 1,897 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000086 · wf-form4_168436187586847.xml · derivative · entry 7

BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,794

Underlying: Common Stock · 1,897 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan).

F5 · derivative.exercise_date: RSU granted on 5/25/2022 vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

F5 · derivative.expiration_date: RSU granted on 5/25/2022 vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

Read SEC document
May 15, 2023 Filed May 17, 2023 22:18 UTC
BERGER DAVID BEVP & Chief Operating Officer
Exercise / conversionRestricted Stock Unit · Derivative 163 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000086 · wf-form4_168436187586847.xml · derivative · entry 6

BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,299

Underlying: Common Stock · 163 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan).

F4 · derivative.exercise_date: RSU granted on 5/18/2021 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

F4 · derivative.expiration_date: RSU granted on 5/18/2021 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

Read SEC document
May 15, 2023 Filed May 17, 2023 22:18 UTC
BERGER DAVID BEVP & Chief Operating Officer
Tax withholdingCommon Stock 656 $32.13 $21,077.28
Disclosure

SEC source: 0001438133-23-000086 · wf-form4_168436187586847.xml · nonDerivative · entry 4

BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,712

F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
May 15, 2023 Filed May 17, 2023 22:18 UTC
BERGER DAVID BEVP & Chief Operating Officer
Exercise / conversionCommon Stock 1,897 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000086 · wf-form4_168436187586847.xml · nonDerivative · entry 3

BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,368

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 15, 2023 Filed May 17, 2023 22:18 UTC
BERGER DAVID BEVP & Chief Operating Officer
Tax withholdingCommon Stock 57 $32.13 $1,831.41
Disclosure

SEC source: 0001438133-23-000086 · wf-form4_168436187586847.xml · nonDerivative · entry 2

BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,471

F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
May 15, 2023 Filed May 17, 2023 22:18 UTC
BERGER DAVID BEVP & Chief Operating Officer
Exercise / conversionCommon Stock 163 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000086 · wf-form4_168436187586847.xml · nonDerivative · entry 1

BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,528

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 15, 2023 Filed May 17, 2023 22:16 UTC
Hansen Shannon MarieSVP & General Counsel
Exercise / conversionRestricted Stock Unit · Derivative 531 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000085 · wf-form4_168436177153029.xml · derivative · entry 4

Hansen Shannon Marie · CIK 0001908267 · SVP & General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,838

Underlying: Common Stock · 531 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan).

F4 · derivative.exercise_date: RSU granted on 2/15/2022 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

F4 · derivative.expiration_date: RSU granted on 2/15/2022 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

Read SEC document
May 15, 2023 Filed May 17, 2023 22:16 UTC
Hansen Shannon MarieSVP & General Counsel
Tax withholdingCommon Stock 184 $32.13 $5,911.92
Disclosure

SEC source: 0001438133-23-000085 · wf-form4_168436177153029.xml · nonDerivative · entry 3

Hansen Shannon Marie · CIK 0001908267 · SVP & General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,570

F2 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
May 15, 2023 Filed May 17, 2023 22:16 UTC
Hansen Shannon MarieSVP & General Counsel
Exercise / conversionCommon Stock 531 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000085 · wf-form4_168436177153029.xml · nonDerivative · entry 2

Hansen Shannon Marie · CIK 0001908267 · SVP & General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,754

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 15, 2023 Filed May 17, 2023 22:16 UTC
Hansen Shannon MarieSVP & General Counsel
GrantCommon Stock 632 $27.32 $17,266.24
Disclosure

SEC source: 0001438133-23-000085 · wf-form4_168436177153029.xml · nonDerivative · entry 1

Hansen Shannon Marie · CIK 0001908267 · SVP & General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,223

F1 · shares: The reporting person is voluntarily reporting the acquisition of shares of common stock pursuant to the Tandem Diabetes Care, Inc. Amended and Restated 2013 Employee Stock Purchase Plan (ESPP), for the ESPP purchase period of November 16, 2022 through May 15, 2023. This transaction is also exempt under Rule 16b-3(c).

Read SEC document
May 15, 2023 Filed May 17, 2023 22:15 UTC
HANSEN BRIAN BEVP & CHIEF COMMERCIAL OFFICER
Exercise / conversionRestricted Stock Unit · Derivative 1,897 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000084 · wf-form4_168436168222335.xml · derivative · entry 7

HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,794

Underlying: Common Stock · 1,897 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan).

F5 · derivative.exercise_date: RSU granted on 5/25/2022 vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

F5 · derivative.expiration_date: RSU granted on 5/25/2022 vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

Read SEC document
May 15, 2023 Filed May 17, 2023 22:15 UTC
HANSEN BRIAN BEVP & CHIEF COMMERCIAL OFFICER
Exercise / conversionRestricted Stock Unit · Derivative 163 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000084 · wf-form4_168436168222335.xml · derivative · entry 6

HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,299

Underlying: Common Stock · 163 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan).

F4 · derivative.exercise_date: RSU granted on 5/18/2021 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

F4 · derivative.expiration_date: RSU granted on 5/18/2021 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.